Literature DB >> 2891726

Effects of long-chain, saturated fatty acids on membrane microviscosity and adrenocorticotropin responsiveness of human adrenocortical cells in vitro.

R W Whitcomb1, W M Linehan, R A Knazek.   

Abstract

Adrenoleukodystrophy (ALD) and adrenomyeloneuropathy are inherited disorders in which long-chain, saturated fatty acids (LCFA) accumulate in various tissues. A mechanism by which LCFA cause the endocrine and neurological dysfunction characteristic of these diseases is proposed based on in vitro response of human adrenocortical cells to ACTH in the presence of various fatty acids. Human adrenocortical cells cultured in the presence of 5 microM hexacosanoic (C26:0) or lignoceric (C24:0) acids showed decreased basal and ACTH-stimulated cortisol release compared with cells cultured without exogenous fatty acids or in the presence of linoleic acid (C18:2). Measurement of fluorescence polarization demonstrates a significant increase in the membrane microviscosity of cells cultured in the presence of LCFA. It is hypothesized that cells exposed to LCFA have increased membrane microviscosity with a consequent decrease in their ability to respond to ACTH. This decrease in trophic support may contribute to the adrenal insufficiency and atrophy in patients with ALD.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2891726      PMCID: PMC442491          DOI: 10.1172/JCI113292

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

1.  Adrenomyeloneuropathy: a probable variant of adrenoleukodystrophy. I. Clinical and endocrinologic aspects.

Authors:  J W Griffin; E Goren; H Schaumburg; W K Engel; L Loriaux
Journal:  Neurology       Date:  1977-12       Impact factor: 9.910

Review 2.  Fluidity parameters of lipid regions determined by fluorescence polarization.

Authors:  M Shinitzky; Y Barenholz
Journal:  Biochim Biophys Acta       Date:  1978-12-15

3.  Dietary essential fatty acids are required for maintenance and induction of prolactin receptors.

Authors:  R A Knazek; S C Liu
Journal:  Proc Soc Exp Biol Med       Date:  1979-11

4.  Arachidonic acid, bradykinin and phospholipase A2 modify both prolactin binding capacity and fluidity of mouse hepatic membranes.

Authors:  J R Dave; R A Knazek; S C Liu
Journal:  Biochem Biophys Res Commun       Date:  1981-11-30       Impact factor: 3.575

5.  Modulation of prolactin binding sites in vitro by membrane fluidizers. II. Age-dependent effects on rat ventral prostatic membranes.

Authors:  J R Dave; R J Witorsch
Journal:  Biochim Biophys Acta       Date:  1984-05-30

6.  Membrane microviscosity is increased in the erythrocytes of patients with adrenoleukodystrophy and adrenomyeloneuropathy.

Authors:  R A Knazek; W B Rizzo; J D Schulman; J R Dave
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

7.  Prostaglandin I2 modifies both prolactin binding capacity and fluidity of mouse liver membranes.

Authors:  J R Dave; R A Knazek
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

8.  Adrenoleukodystrophy: effects of dietary restriction of very long chain fatty acids and of administration of carnitine and clofibrate on clinical status and plasma fatty acids.

Authors:  F R Brown; M A Van Duyn; A B Moser; J D Schulman; W B Rizzo; R D Snyder; J V Murphy; S Kamoshita; C J Migeon; H W Moser
Journal:  Johns Hopkins Med J       Date:  1982-10

9.  Indomethacin causes a simultaneous decrease of both prolactin binding and fluidity of mouse liver membranes.

Authors:  R A Knazek; S C Liu; J R Dave; R J Christy; J A Keller
Journal:  Prostaglandins Med       Date:  1981-04

10.  Effects of dietary essential fatty acids on murine mammary gland development.

Authors:  R A Knazek; S C Liu
Journal:  Cancer Res       Date:  1981-09       Impact factor: 12.701

View more
  42 in total

1.  X-linked adrenoleukodystrophy: first report of the Italian Study Group.

Authors:  A Di Biase; S Salvati; C Avellino; M Cappa; E Bertini; I Moroni; M Rimoldi; G Uziel
Journal:  Ital J Neurol Sci       Date:  1998-10

Review 2.  X linked adrenoleukodystrophy: clinical presentation, diagnosis, and therapy.

Authors:  B M van Geel; J Assies; R J Wanders; P G Barth
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-07       Impact factor: 10.154

3.  ABCD1 deletion-induced mitochondrial dysfunction is corrected by SAHA: implication for adrenoleukodystrophy.

Authors:  Mauhamad Baarine; Craig Beeson; Avtar Singh; Inderjit Singh
Journal:  J Neurochem       Date:  2015-01-13       Impact factor: 5.372

Review 4.  Evaluation of therapy of X-linked adrenoleukodystrophy.

Authors:  Hugo W Moser; Ali Fatemi; Kathleen Zackowski; Seth Smith; Xavier Golay; Larry Muenz; Gerald Raymond
Journal:  Neurochem Res       Date:  2004-05       Impact factor: 3.996

5.  Adrenal steroids in adrenomyeloneuropathy. Dehydroepiandrosterone sulfate, androstenedione and 17alpha-hydroxyprogesterone.

Authors:  Maria Wichers-Rother; Andreas Grigull; Piotr Sokolowski; Birgit Stoffel-Wagner; Wolfgang Köhler
Journal:  J Neurol       Date:  2005-12       Impact factor: 4.849

6.  Molecular species of phospholipids with very long chain fatty acids in skin fibroblasts of Zellweger syndrome.

Authors:  Kotaro Hama; Toru Nagai; Chiho Nishizawa; Kazutaka Ikeda; Masashi Morita; Noriko Satoh; Hiroki Nakanishi; Tsuneo Imanaka; Nobuyuki Shimozawa; Ryo Taguchi; Keizo Inoue; Kazuaki Yokoyama
Journal:  Lipids       Date:  2013-12       Impact factor: 1.880

Review 7.  Very long-chain fatty acids in diagnosis, pathogenesis, and therapy of peroxisomal disorders.

Authors:  H W Moser; A B Moser
Journal:  Lipids       Date:  1996-03       Impact factor: 1.880

8.  Clinical profile of adrenoleukodysrophy.

Authors:  Shrikrishna V Acharya; Raju A Gopal; Tushar R Bandgar; Shashank R Joshi; Padma S Menon; Nalini S Shah
Journal:  Indian J Pediatr       Date:  2009-11-12       Impact factor: 1.967

9.  Plasma and red blood cell fatty acids in peroxisomal disorders.

Authors:  A B Moser; D S Jones; G V Raymond; H W Moser
Journal:  Neurochem Res       Date:  1999-02       Impact factor: 3.996

Review 10.  Adrenoleukodystrophy: phenotypic variability and implications for therapy.

Authors:  H W Moser; A B Moser; K D Smith; A Bergin; J Borel; J Shankroff; O C Stine; C Merette; J Ott; W Krivit
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.